Boundless Bio, Inc. (BOLD)
↓ Download CSVKey ratios (FY2025)
-59.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$63.55M | -$73.27M | -$54.80M | — |
| Net Income | -$58.20M | -$65.36M | -$49.43M | — |
| EPS (Diluted) | $-2.60 | $-3.85 | $-40.65 | — |
| Total Assets | $157.06M | $206.41M | $129.89M | — |
| Total Liabilities | $58.41M | $55.77M | $9.36M | — |
| Shareholders' Equity | $98.65M | $150.64M | -$127.08M | -$81.70M |
| Cash & Equivalents | $17.87M | $26.59M | $23.71M | — |
| Operating Cash Flow | -$46.66M | -$60.84M | -$46.85M | — |
| Capital Expenditures | $546.0K | $2.54M | $633.0K | — |
| Shares Outstanding | 22.41M | 22.30M | 1.2K | — |